| 1JFN | A:25-102 | SOLUTION STRUCTURE OF HUMAN APOLIPOPROTEIN(A) KRINGLE IV TYPE 6 |
| 1KIV | A:1-80 | RECOMBINANT KRINGLE IV-10/M66 VARIANT OF HUMAN APOLIPOPROTEIN(A) |
| 3KIV | A:1-80 | RECOMBINANT KRINGLE IV-10/M66 VARIANT OF HUMAN APOLIPOPROTEIN(A) |
| 1NK1 | B:128-206; B:128-206 | NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AT 2.5 ANGSTROM RESOLUTION |
| 2QJ2 | B:1128-1206; B:1128-1206 | A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST |
| 3MKP | D:128-206; D:128-206; D:128-206; D:128-206 | CRYSTAL STRUCTURE OF 1K1 MUTANT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR FRAGMENT NK1 IN COMPLEX WITH HEPARIN |
| 1KI0 | A:256-333; A:256-333; A:256-333 | THE X-RAY STRUCTURE OF HUMAN ANGIOSTATIN |
| 1KRN | A:66-143 | STRUCTURE OF KRINGLE 4 AT 4C TEMPERATURE AND 1.67 ANGSTROMS RESOLUTION |
| 1PK4 | A:1-80 | CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN PLASMINOGEN KRINGLE 4 REFINED AT 1.9-ANGSTROMS RESOLUTION |
| 1PKR | A:1-80 | THE STRUCTURE OF RECOMBINANT PLASMINOGEN KRINGLE 1 AND THE FIBRIN BINDING SITE |
| 1PMK | B:1-80; B:1-80 | KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURES |
| 2KNF | A:1-80 | SOLUTION STRUCTURE AND FUNCTIONAL CHARACTERIZATION OF HUMAN PLASMINOGEN KRINGLE 5 |
| 2L0S | A:1-80 | SOLUTION STRUCTURE OF HUMAN PLASMINOGEN KRINGLE 3 |
| 3K65 | A:170-248 | CRYSTAL STRUCTURE OF PRETHOMBIN-2/FRAGMENT-2 COMPLEX |
| 3NXP | A:170-248 | CRYSTAL STRUCTURE OF HUMAN PRETHROMBIN-1 |
| 1PK2 | A:7-88 | SOLUTION STRUCTURE OF THE TISSUE-TYPE PLASMINOGEN ACTIVATOR KRINGLE 2 DOMAIN COMPLEXED TO 6-AMINOHEXANOIC ACID AN ANTIFIBRINOLYTIC DRUG |
| 1TPK | C:1-80; C:1-80; C:1-80 | CRYSTAL STRUCTURE OF THE KRINGLE-2 DOMAIN OF TISSUE PLASMINOGEN ACTIVATOR AT 2.4-ANGSTROMS RESOLUTION |
| 1KDU | A:1-80 | SEQUENTIAL 1H NMR ASSIGNMENTS AND SECONDARY STRUCTURE OF THE KRINGLE DOMAIN FROM UROKINASE |
| 1URK | A:50-131 | SOLUTION STRUCTURE OF THE AMINO TERMINAL FRAGMENT OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR |
)
)